Stay updated with breaking news from Synlogic Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Chardan Capital reaffirmed their buy rating on shares of Synlogic (NASDAQ:SYBX – Free Report) in a research report sent to investors on Friday, Benzinga reports. The brokerage currently has a $6.00 price objective on the biotechnology company’s stock. Separately, HC Wainwright reiterated a buy rating and set a $5.00 price target on shares of Synlogic […]
10.08.2023 - Recent milestones include initiation of the pivotal Phase 3 trial, Synpheny-3, and receipt of Fast Track designation for labafenogene marselecobac as a potential treatment for PKUCAMBRIDGE, Mass., Aug. 10, 2023 (GLOBE NEWSWIRE) - Synlogic, Inc. ...
Daiichi Sankyo (OTCMKTS:DSNKY – Get Free Report) and Roche (OTCMKTS:RHHVF – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, dividends, risk, profitability, earnings and institutional ownership. Analyst Recommendations This is a breakdown of current ratings […]
Daiichi Sankyo (OTCMKTS:DSNKY – Get Free Report) and Roche (OTCMKTS:RHHVF – Get Free Report) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, valuation, profitability, earnings, institutional ownership and risk. Profitability This table compares Daiichi Sankyo and Roche’s net […]
Global Human Microbiome Therapeutics Market 2023-2027. The human microbiome therapeutics market is forecasted to grow by USD 732.95 mn during 2022-2027,...